ARCHIVES

FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight

This article is from The Cancer Letter archive.

Vol. 36 No. 46 | December 17, 2010

Download PDF Visit The Full Archive

Related Articles

Cancer Groups Oppose Plan To Cut Drug Reimbursement.

July 28, 2000

AVEO’s Tizozanib Fails in Colorectal Cancer

January 10, 2014

Cancer Screening Priorities Questioned In Dartmouth Study

March 28, 2003

Britain’s Cancer Czar Begins Examination of Risks and Benefits of Mammography

October 28, 2011

FDA To Once Again Review ESA Label To Reflect Results Of Negative Studies.

December 7, 2007

NCAB Approves Funding for New Construction At Georgetown, Yale

June 3, 1977